Risks of pelvic inflammatory disease and bacterial vaginosis in adenomyosis patients using levonorgestrel intrauterine device or oral norethindrone.

Front Endocrinol (Lausanne) · 2025 · PMC12702703 · PMID 41404506

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

Although BV showed a similar trend toward a higher incidence in the LNG-IUD group, the difference did not reach statistical significance (HR 1.239; 95% CI 0.819–1.874).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.